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Fasamycin natural products are biosynthetic precursors of the formicamycins. Both groups of compounds
are polyketide natural products that exhibit potent antibacterial activity despite displaying different three-
dimensional topologies. We show here that transformation of fasamycin into formicamycin metabolites
requires two gene products and occurs via a novel two-step ring expansion-ring contraction pathway.
Deletion of forX, encoding a flavin dependent monooxygenase, abolished formicamycin production and
leads to accumulation of fasamycin E. Deletion of the adjacent gene forY, encoding a flavin dependent
oxidoreductase, also abolished formicamycin biosynthesis and led to the accumulation of new lactone
metabolites that represent Baeyer–Villiger oxidation products of the fasamycins. These results identify
ForX as a Baeyer–Villiger monooxygenase capable of dearomatizing ring C of the fasamycins. Through in
vivo cross feeding and biomimetic semi-synthesis experiments we showed that these lactone products
represent biosynthetic intermediates that are reduced to formicamycins in a unique reductive ring
contraction reaction catalyzed by ForY.Introduction
Bacterial aromatic polyketide natural products comprise an
extensive family of biosynthetically related molecules that
encompass great structural variety and oen display potent
biological activity.1 They include several important clinical
agents, for example the tetracycline antibiotics and anthracy-
cline antineoplastic drugs. The carbon skeletons of aromatic
polyketides are invariably derived from the function of disso-
ciated type II polyketide synthases (PKSs), and additional
structural diversity is introduced by tailoring enzymes following
polyketide biosynthesis.2,3 Such post-PKS transformations
include acylation, alkylation, glycosylation and halogenation, as
well as redox changes. Further structural complexity can be
introduced via carbon–carbon bond cleavage and rearrange-
ments in processes commonly catalyzed by oxidative enzymes.
Illustrative examples include the reactions catalyzed by avin-
dependent Baeyer–Villiger (BV) monooxygenase enzymes4
during the biosynthesis of the jadomycins,5 gilvocarcins5 and
chartreusins6 amongst others.n Innes Centre, Norwich Research Park,
inson@jic.ac.uk
of East Anglia, Norwich Research Park,
gs@jic.ac.uk
h, Claverton Down, Bath BA2 7AY, UK
(ESI) available: General remarks; full
les S1–S5. See DOI: 10.1039/d0sc01712d
is work.
of Chemistry 2020We recently described the formicamycins, poly-
halogenated tridecaketides that are co-products, along with
the fasamycins, of the Streptomyces formicae KY5 for biosyn-
thetic gene cluster (BGC; Fig. 1 and S1†) encoding a type II
PKS.7 The fasamycins exhibit potent antibacterial activity and
congeners were reported from heterologous expression of
environmental DNA and were encoded by a clone expressing
a type II PKS BGC, but no co-produced formicamycins were
reported.8 Despite their common biosynthetic origin and
carbon backbone connectivity, the fasamycins and for-
micamycins have very different three-dimensional structures
as determined from NOESY NMR, ECD spectroscopy and
computational modelling.7 Moreover, the formicamycins dis-
played more potent antibacterial activity and a barrier for the
selection of resistant isolates.
Mutational analysis of the formicamycin (for) BGC identi-
ed a single avin dependent halogenase (ForV) that can
presumably catalyze multiple halogenation events.7 Deletion
of forV abolished the production of all halogenated congeners
and the DforV mutant produced only a single compound
fasamycin C 1 but no formicamycins (Fig. 2b); the deletion
could be complemented by ectopic expression of forV.7 This
suggests a gatekeeper function for ForV, meaning the enzymes
which convert fasamycins to formicamycins operate on halo-
genated intermediates, conrming that the fasamycins are
biosynthetic precursors of the formicamycins. Structural
comparison of the two skeletons indicates that unusual
biosynthetic transformations are required to enable their
interconversion, involving a dearomatization of fasamycin ringChem. Sci.
Fig. 1 Chemical skeletons of fasamycins (1–3) and formicamycins (4–16) isolated from S. formicae KY5, and Baeyer–Villiger lactone inter-
mediates (17–21) isolated from the S. formicae DforY mutant in this study (for detailed substituent variations including halogenation or O-
methylation, see Fig. S1†). The 2D NMR structure determination of 18 is shown by COSY (bold), NOESY (red double-head arrow), and selected
HMBC (blue single-head arrow) correlations respectively. R1–4 ¼ H or Cl; R5 ¼ H or CH3.
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View Article OnlineC via a formal tautomerization and two-electron reduction,
plus the introduction of a tertiary hydroxyl group at C10. This
suggests the requirement for a reductive enzyme in addition to
a monooxygenase. These intriguing biosynthetic observations,
in concert with their antibacterial properties, prompted us to
study the biosynthetic steps linking the two compound
families.Results
Bioinformatics analysis
The for BGC was sequenced previously7 and comparison to
the originally reported fasamycin BGC8 did not identify any
additional genes obviously responsible for formicamycin
biosynthesis. However, comparison to a for-like BGC identi-
ed in a 140 kbp region of the Streptomyces kanamyceticus
genome that is syntenic with S. formicae KY5 (Genbank ID
LIQU00000000.1), identied a set of four grouped genes
forX–forAA which are not present in S. kanamyceticus (Fig. 3).
A similar observation was made when we compared the for
BGC to the recently reported BGC encoding production of
accramycin A, a new fasamycin congener.9 Three of these
gene products (ForY, ForZ and ForAA) show high homology
to sequences from Actinomadura species, suggesting they
may have been acquired via horizontal gene transfer. The
gene product ForX is a putative avin-dependent mono-
oxygenase, and both sequence homology and predicted
structural homology10 searches indicated the most closely
related characterized homologue is aklavinone 12-hydroxy-
lase (RdmE) (Table 1), a Group A avin-dependent mono-
oxygenase.11,12 Group A monooxygenases are reported toChem. Sci.catalyze hydroxylation or sulfoxidation. Sequence align-
ments of ForX and RdmE showed an overall identity of 41%,
with three noticeable regions of low homology between
residues 70–119, 212–245 and 365–393 in the RdmE structure
(31HG), corresponding to the substrate binding pocket.
Structural homology searches predicted ForY to be a TIM
beta/alpha barrel oxidoreductase (Table 1), homologues of
which typically utilize avin cofactors to perform redox
chemistry.13–17 The genes forZ and forAA encode a MarR
family transcriptional regulator and an MFS family trans-
porter respectively.
Mutational analysis identies a two-step biosynthetic
transformation
Guided by our bioinformatic observations we made individual
in-frame deletions in forX and forY using Cas9 mediated gene
editing. The resulting mutants failed to produce for-
micamycins, but this was restored aer ectopic expression of
the deleted genes (Fig. S2†). Despite producing no for-
micamycins, S. formicae DforX accumulated the previously
isolated fasamycin E (3) (Fig. 2c) which was conrmed by
isolation and NMR characterization (Fig. S3 and S4†). This is
consistent with the hypothesis that ForX catalyzes an oxida-
tion required for formicamycin biosynthesis, and that it
functions on halogenated fasamycin substrates. In contrast, S.
formicae DforY accumulated six new compounds 17–22
(Fig. 2d). Aer scaling up fermentation (4 L) and solvent
extraction, a small amount of each of the congeners 17–21 (5–
13 mg) was isolated and subjected to structure determination
using 2D NMR and MS. Compound 22 could not be isolated
but analytical MS and UV data were consistent with it beingThis journal is © The Royal Society of Chemistry 2020
Fig. 2 Mutational analysis of the tailoring enzyme encoding genes
involved in formicamycin biosynthesis. Deletion of forX abolishes the
production of formicamycins but leads to accumulation of fasamycin E
(3). Deletion of forY abolishes the production of formicamycins and
leads to accumulation of six biosynthetic intermediates (17–22).
Reconstituted HPLC traces (UV ¼ 285 nm) showing: (a) S. formicae
wild type; (b) S. formicae DforV (for details see ref. 7); (c) S. formicae
DforX; (d) S. formicae DforY.
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View Article Onlinea related biosynthetic congener. We rst determined the
structure of 18 because high-resolution ESI-MS predicted
a molecular formula of C28H22O8Cl2 indicating one more
oxygen atom compared with 3, but with a distinct UV spec-
trum (lmax 248 and 300 nm vs. 249, 289, 355, and 415 nm for 3)
indicating a major structural change. 1D and 2D NMR exper-
iments showed a striking low- to high-eld chemical shi for
the carbonyl group (C11) in comparison to 3, in addition to the
appearance of new methylene and lactone carbonyl moieties.
Based on these observations, and other connectivity, we
assigned the structure of 18 as a Baeyer–Villiger lactone
derivative of 3 (Fig. 1). Further analysis identied 19 as the C5-
O-methyl congener of 18, and 17 as lacking a chlorine atom at
C2 when compared to 18. The remaining two congeners 20
and 21 were determined to contain further variations in
chlorination and O-methylation (Fig. S1†).This journal is © The Royal Society of Chemistry 2020These results are consistent with a two-step ring
expansion-ring contraction pathway for the conversion of
fasamycins into formicamycins with ForX catalyzing a Baeyer–
Villiger reaction on fasamycin substrates, and ForY catalyzing
the two-electron reduction of the Baeyer–Villiger intermedi-
ates with concomitant ring contraction via hydride addition
at C19. To provide support for our hypothesis we attempted to
express and isolate both proteins for biochemical analysis
but, despite extensive experimentation, we were unable to
obtain soluble protein. Undeterred, we instead utilized
biomimetic chemical synthesis to investigate the biosynthetic
pathway (see below), but rst veried the intermediacy of the
isolated lactones through a cross feeding experiment. Exoge-
nous 18 (isolated from S. formicae DforY) was added to
growing cultures of the S. formicae DforX biosynthetic mutant
and aer nine days incubation LCMS analysis of an ethyl
acetate extract of the culture broth indicated that 18 was
converted efficiently into the previously isolated for-
micamycin congeners 5, 8, 9, and 13 plus the O-methylated
lactone 19 (Fig. S5†). This is consistent with 18 being a direct
biosynthetic intermediate of the formicamycins and a puta-
tive substrate of ForY.Biomimetic semi-synthesis of the formicamycins
To mimic the ForY catalyzed biosynthetic transformation we
subjected an analytical sample (0.1 mg) of the lactone 19 to
sodium borohydride reduction (Fig. 4a). This yielded three
new products with a mass increase of 2 Da, plus an addi-
tional compound with a mass decrease of 14 Da (Fig. 4b).
Notably, and in contrast to 19, the products 23 and 24
(0.97 : 1 ratio) displayed formicamycin like UV spectra
(Fig. 4c). The reaction was then scaled up (using 4 mg of 19)
and the products 23 (0.4 mg) and 24 (0.2 mg) were puri-
ed by HPLC. 2D NMR experiments indicated that these
both contained the formicamycin ring structure, consistent
with the proposed reduction and ring contraction mecha-
nism (Fig. S59†). Chemical shi comparisons to biosynthetic
congeners, in addition to 1D NOE data, conrmed that 23
corresponds to the natural (10RS,19RS) diastereoisomer and
24 to the (10RS,19SR) diastereoisomer. The product 25 (0.4
mg) was isolated with 24 (1 : 1 mixture) and NMR analysis
clearly showed 25 to be a lactone in which the C10–C19
double bond was reduced but for which rearrangement via
ring contraction had not occurred. NMR analysis then
showed that 25 corresponds to a single diastereoisomer and
the NOESY spectrum showed a strong correlation between
H-10 and H-19 indicating the (10RS,19RS) conguration. The
NMR and MS data for the remaining 14 Da component is
consistent with deoxygenation at C11 as shown for 26
(Fig. 4). The biomimetic reaction was then repeated using
lactone congener 17 (5.4 mg) as the starting material and
analysis of the products showed an almost identical
outcome to that for sodium borohydride reduction of 19
(Fig. S6†).
To better understand their stereochemical composition,
we determined the [a]D
20 values of 23 and 24 to be +68 andChem. Sci.
Fig. 3 Comparison of the fasamycin/formicamycin biosynthetic gene clusters (top) and the alternate pathways for each step of the proposed
two-step ring expansion-contraction mechanism of formicamycin biosynthesis from fasamycin E (3) (bottom).
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View Article Online73 respectively indicating that the reductive trans-
formation had occurred with induction of chirality, most
probably due to the Sa-atropoisomeric axis of the C6–C7
bond deriving from the fasamycin precursors. The xedChem. Sci.atropoisomeric axis was conrmed by determining the
rotational energy barrier for the C6–C7 bond of fasamycin C
(1) using DFT calculations (see ESI†). This yielded a value of
DE ¼ 156.1 kJ mol1 indicating that little to no axial rotationThis journal is © The Royal Society of Chemistry 2020
Fig. 4 Biomimetic reduction of the biosynthetic intermediate 19 and isolated products. (b) HPLC-UV (285 nm) trace of the initial reaction
products from (a); (c) UV spectra of the reaction substrate (19), twomain products of interest (23 and 24), plus formicamycin B (5) as a standard for
comparison.
Table 1 Characteristics of for BGC gene products discussed in this study
Name Accession number Top hit
%
coverage
%
identity
ForX WP_049717083.1 Hypothetical protein, Streptomyces caatingaensis 94 50
ForY WP_089326038.1 LLM class avin-dependent oxidoreductase, Actinomadura meyerae 87 60
ForZ WP_121435158.1 MarR transcriptional regulator, Actinomadura pelletieri 84 42
ForAA WP_122199503.1 DHA2 family efflux MFS transporter permease subunit, Actinomadura sp. NEAU-Ht49 96 57
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View Article Onlineshould be expected about this bond, with the frequency of
rotation on the order of years.18 The positive sign of the
[a]D
20 for 23 is consistent with all previous naturally occur-
ring formicamycins which have [a]D
20 values in the range
+162 to +469. Unfortunately, we had not isolated the for-
micamycin congener 23 in our previous work and therefore
could not assign the enantiomeric excess of this molecule
based on optical rotation comparison to a standard. While
the isolated sample of 23 is a mixture of two enantiomers at
C10/C19, given the essentially xed atropoisomeric axis at
C6–C7, these two molecules should be diastereotopic with
respect to each other. However, the 1H NMR spectrum for
this sample did not indicate split chemical shis at any
position and the initial HPLC analysis showed a single peak.
We thus repeated the chromatographic analysis using theThis journal is © The Royal Society of Chemistry 2020higher resolving power of UPLC, and varied the elution
conditions, and were able to resolve the isolated sample of
23 into two peaks of the same mass and with the same UV
spectra (Fig. 5) consistent with their diastereotopic rela-
tionship. Integration of these two peaks indicated a diaste-
reomeric excess (% de) of 41.3%. The equivalent analysis of
isolated 24 indicated a % de of 40.5%. Mixing the isolated
samples of 23 and 24 and repeating the UPLC analysis
conrmed the presence of 4 peaks, whereas reanalysis of this
mixture using the original HPLC conditions showed only 2
peaks, consistent with no change to the sample following
purication. UPLC analysis of formicamycins isolated from
S. formicae KY5 indicated all congeners were single
diastereoisomers.Chem. Sci.
Fig. 5 Reconstituted UPLC-UV (285 nm) analysis for the isolated
reduction products 23 (a), 24 (b), and amixture of the isolated products
(c) indicating the diastereomeric composition of these samples.
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View Article OnlineConclusions
The two-step pathway described here explains the signicant
structural changes that must occur to transform the almost at
fasamycin skeleton into the twisted chair-like conguration of
the formicamycins. The dearomatization of aromatic systems as
a prelude to structural diversication has been described for
several natural products including, for example, recent muta-
tional analysis of the agnestins19 and cryptosporioptides20
where deletion of genes encoding putative Baeyer–Villigerases
led to accumulation of the anticipated aromatic precursors. For
the Baeyer–Villiger activity of ForX, two alternative mechanisms
can be invoked for reaction between the fasamycin substrate,
reduced avin cofactor and oxygen. In the rst pathway
(Pathway I) the peroxyavin species acts as an electrophile to
catalyze oxygen introduction as a tertiary hydroxyl group at C10
following deprotonation of the adjacent phenol (Fig. 3).
Subsequent rearrangement then occurs with bond migration
and protonation at C20. Alternatively, (Pathway II) ForX could
rst induce tautomerization of ring C, possibly through
substrate binding, followed by donation of a proton from the
peroxyavin cofactor to the resulting C9 ketone generating an
oxonium intermediate. The resulting avoperoxy anion can
then act as a nucleophile in a canonical BV-like reaction to
generate the observed lactone intermediate. The tautomeriza-
tion required in the rst step of Pathway II has precedent in the
reaction of dehydrorabelomycin and congeners during the
biosynthesis of gilvocarcins and jadomycins.5However, we favor
Pathway I which is reminiscent of that by which a nucleophilicChem. Sci.chloride ion is converted into a highly reactive electrophilic
species via the intermediacy of hypochlorous acid by avin-
dependent halogenases.21 This is consistent with our observa-
tion that ForX groups phylogenetically with the Group A mon-
ooxygenases that typically catalyze hydroxylation.
We propose that ForY then acts as a avin-dependent
reductase catalyzing two-electron reduction of the interme-
diate lactone. This reaction most likely proceeds via 1,4-conju-
gate attack of a hydride ion at C19 to form the corresponding
enolate 27. Collapse of the enolate can then occur with forma-
tion of the new C9–C10 sigma bond and formation of an
epoxide intermediate with subsequent rearrangement to yield
the C10-tertiary hydroxyl group with overall ring contraction in
a process reminiscent of a Favorskii reaction. This pathway
(Fig. 3) is consistent with the side products observed in the
sodium borohydride biomimetic reduction, and with the steric
requirements for orbital overlap during C9–C10 bond forma-
tion. Although rare in nature a Favorskii-type reaction has been
demonstrated to occur during biosynthesis of the polyketide
natural product enterocin produced by Streptomyces mar-
itimus.22 This pathway involves oxidative activation of the
preceding intermediate via a dual 4-electron oxidation. The
reaction is catalyzed by the unique avin dependent mono-
oxygenase EncM which utilizes a avin-N5-oxide, rather than
a peroxyavin intermediate, to catalyze substrate oxidation and
trigger a Favorskii-type reaction.23 Oxidation promotes further
aldol and heterocylization reactions which are also mediated by
EncM.22,23 Based on the outcome of careful stable isotope
labeling experiments, a Favorskii-like reaction has also been
proposed to occur during biosynthesis of the fungal polyketide
metabolite roussoellatide.24
The production of a single steric isomer during the biosyn-
thesis of formicamycins and the lack of any conjugate reduction
side products as are observed during the sodium borohydride
biomimetic reduction of isolated lactone biosynthetic interme-
diates indicates that ForY must control both the stereochemical
progress of this reaction and limit alternative reaction coordi-
nates. As described, the proposed reductive ring contraction
catalyzed by ForY is unique in polyketide biosynthesis and future
work will seek to understand this novel biochemical process in
greater detail. A search of all available microbial genome
sequences did not identify any additional close homologues.
Further searches using MultiGeneBlast25 with sequences for the
minimal PKS genes plus forX, with and without forY, failed to
identify any additional candidate BGCs that might encode path-
ways that operate as described here suggesting that this pathway
is unique to formicamycin biosynthesis.
Materials and methods
For details regarding experimental procedures, microbiology
and molecular biology procedures, spectroscopic data, see the
ESI.†
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